Hofe Eric Von - Net Worth and Insider Trading

Hofe Eric Von Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hofe Eric Von owns 1 companies in total, including Generex Biotechnology Corp (GNBTQ) .

Click here to see the complete history of Hofe Eric Von’s form 4 insider trades.

Insider Ownership Summary of Hofe Eric Von

Ticker Comapny Transaction Date Type of Owner
GNBTQ Generex Biotechnology Corp 2016-02-09 director & President of Subsidiary

Hofe Eric Von Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hofe Eric Von Ownership Network

Ownership Network List of Hofe Eric Von

No Data

Ownership Network Relation of Hofe Eric Von

Insider Network Chart

Hofe Eric Von Owned Company Details

What does Generex Biotechnology Corp do?

Who are the key executives at Generex Biotechnology Corp?

Hofe Eric Von is the director & President of Subsidiary of Generex Biotechnology Corp. Other key executives at Generex Biotechnology Corp include other: Consultant Harold Gray Haines , EVP General Counsel &Secretary Mark Fletcher , and CFO & Treasurer Mark Corrao .

Generex Biotechnology Corp (GNBTQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Generex Biotechnology Corp (GNBTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Generex Biotechnology Corp (GNBTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Generex Biotechnology Corp (GNBTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Generex Biotechnology Corp Insider Transactions

No Available Data

Hofe Eric Von Mailing Address

Above is the net worth, insider trading, and ownership report for Hofe Eric Von. You might contact Hofe Eric Von via mailing address: 4145 North Service Road, Suite 200 Burlington A6 L7l6a3.

Discussions on Hofe Eric Von

No discussions yet.